このエントリーをはてなブックマークに追加
ID 30703
JaLCDOI
FullText URL
Author
Ohnoshi, Taisuke
Oka, Akira
Hayashi, Kyoichi
Ueoka, Hiroshi
Sato, Masaharu
Nishihara, Ryuji
Yasuoka, Masatoshi
Sando, Yasuhiro
Tanaka, Toshio
Kimura, Ikuro
Abstract

Eighteen patients with advanced non-Hodgkin's lymphoma other than the diffuse histiocytic type were treated with a combination of adriamycin, vincristine, ifosfamide and prednisolone (AVIP). The objective response rate was 83% (15/18); 61% (11/18) achieved complete remission. The median duration of complete remission was 11 months ranging from 2 to 39+ months. Eleven of the 18 patients are still alive during the median follow-up time of 13 months. The median survival was 14+ months for complete responders, and 9.5 months for partial and nonresponders. A myelosuppressive toxicity was well tolerated. AVIP offers some hope as treatment of advanced non-Hodgkin's lymphoma.

Keywords
non-Hodgkin's lymphoma
combination chemotherapy
Amo Type
Article
Publication Title
Acta Medica Okayama
Published Date
1982-02
Volume
volume36
Issue
issue1
Publisher
Okayama University Medical School
Start Page
67
End Page
72
ISSN
0386-300X
NCID
AA00508441
Content Type
Journal Article
language
English
File Version
publisher
Refereed
True
PubMed ID
Web of Science KeyUT